NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









General Biosystems, Inc.

General Biosystems, Inc.

Private
Morrisville, North CarolinaHealthcare & Life Scienceshttps://www.generalbiosystems.com/

Last Round

Growth Equity

Jun 29, 2022

Total Funding Raised

$14.9M

Company Overview

General Biosystems, Inc. is a biotechnology company that provides synthetic biology services, including gene synthesis, protein expression, and molecular biology solutions for research and development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

gene synthesissynthetic biologyDNA synthesissynbiocustom DNA servicesoligo synthesisprotein expressionplasmid preparationbiotech manufacturingcodon optimizationcontract research organizationmetabolic engineeringCRODNA cloningsite-directed mutagenesis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

General Biosystems, Inc. Comps

Public and private peers based on sector, stage, and business model.

General Biosystems, Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

General Biosystems, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Growth EquityJun 29, 2022
Series AApr 28, 2021

General Biosystems, Inc. Investors

Notable investors and investment history

General Biosystems, Inc. investors
InvestorRounds
Jifeng VenturesSeries A
Zhejiang Sino Wisdom Investment ManagementGrowth Equity
华义创投 (Huayi Venture Capital)Series A
Addor CapitalSeries A

General Biosystems, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

General Biosystems, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about General Biosystems, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersMorrisville, North Carolina
Employee Range5
Year Founded2013
Last FundingJun 29, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.